News

MSD begins Phase III trial of dengue vaccine
Merck & Co (MSD) has initiated the randomised MOBILIZE-1 Phase III trial to assess the immunogenicity, efficacy, and safety ...
Healio51m
Staying ‘as mobile as possible’ critical to curbing osteoporosis in rheumatoid arthritis
Managing rheumatoid arthritis-associated osteoporosis requires an ongoing, multidisciplinary effort to prevent bone loss, ...